220 related articles for article (PubMed ID: 24234423)
1. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress.
Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
Mol Cell Biochem; 2014 Feb; 387(1-2):261-70. PubMed ID: 24234423
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
Peng L; Wang R; Shang J; Xiong Y; Fu Z
Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
[TBL] [Abstract][Full Text] [Related]
3. Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling.
Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
Cancer Lett; 2014 Feb; 343(2):190-9. PubMed ID: 24125860
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
5. Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer.
Peng L; Jiang J; Chen HN; Zhou L; Huang Z; Qin S; Jin P; Luo M; Li B; Shi J; Xie N; Deng LW; Liou YC; Nice EC; Huang C; Wei Y
Cell Rep; 2021 Nov; 37(9):110069. PubMed ID: 34852234
[TBL] [Abstract][Full Text] [Related]
6. PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells.
Zheng X; Wei J; Li W; Li X; Wang W; Guo J; Fu Z
Aging (Albany NY); 2020 Jul; 12(16):16390-16409. PubMed ID: 32692719
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of peroxiredoxin 2 inhibits TGF-β1-induced epithelial-mesenchymal transition and cell migration in colorectal cancer.
Feng J; Fu Z; Guo J; Lu W; Wen K; Chen W; Wang H; Wei J; Zhang S
Mol Med Rep; 2014 Aug; 10(2):867-73. PubMed ID: 24920174
[TBL] [Abstract][Full Text] [Related]
8. Prdx2 Upregulation Promotes the Growth and Survival of Gastric Cancer Cells.
Zhang S; He J; Tang M; Sun H
Pathol Oncol Res; 2020 Jul; 26(3):1869-1877. PubMed ID: 31807984
[TBL] [Abstract][Full Text] [Related]
9. Repurposing Oxiconazole against Colorectal Cancer via PRDX2-mediated Autophagy Arrest.
Shi J; Zhou L; Huang HS; Peng L; Xie N; Nice E; Fu L; Jiang C; Huang C
Int J Biol Sci; 2022; 18(9):3747-3761. PubMed ID: 35813474
[TBL] [Abstract][Full Text] [Related]
10. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer.
Wang S; Chen Z; Zhu S; Lu H; Peng D; Soutto M; Naz H; Peek R; Xu H; Zaika A; Xu Z; El-Rifai W
Redox Biol; 2020 Jan; 28():101319. PubMed ID: 31536951
[TBL] [Abstract][Full Text] [Related]
11. PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53.
Wang W; Wei J; Zhang H; Zheng X; Zhou H; Luo Y; Yang J; Deng Q; Huang S; Fu Z
Cell Death Dis; 2021 Jun; 12(6):605. PubMed ID: 34117220
[TBL] [Abstract][Full Text] [Related]
12. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells.
Chen X; Zhao Y; Luo W; Chen S; Lin F; Zhang X; Fan S; Shen X; Wang Y; Liang G
Theranostics; 2020; 10(22):10290-10308. PubMed ID: 32929349
[No Abstract] [Full Text] [Related]
13. Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation.
Chuerduangphui J; Ekalaksananan T; Heawchaiyaphum C; Vatanasapt P; Pientong C
PLoS One; 2020; 15(12):e0242465. PubMed ID: 33332365
[TBL] [Abstract][Full Text] [Related]
14. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs.
Stresing V; Baltziskueta E; Rubio N; Blanco J; Arriba MC; Valls J; Janier M; Clézardin P; Sanz-Pamplona R; Nieva C; Marro M; Petrov D; Sierra A
Oncogene; 2013 Feb; 32(6):724-35. PubMed ID: 22430214
[TBL] [Abstract][Full Text] [Related]
16. Role of peroxiredoxin2 downregulation in recurrent miscarriage through regulation of trophoblast proliferation and apoptosis.
Wu F; Tian F; Zeng W; Liu X; Fan J; Lin Y; Zhang Y
Cell Death Dis; 2017 Jun; 8(6):e2908. PubMed ID: 28661480
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
18. S-nitrosylation of the Peroxiredoxin-2 promotes S-nitrosoglutathione-mediated lung cancer cells apoptosis via AMPK-SIRT1 pathway.
Zhang Y; Sun C; Xiao G; Shan H; Tang L; Yi Y; Yu W; Gu Y
Cell Death Dis; 2019 Apr; 10(5):329. PubMed ID: 30988280
[TBL] [Abstract][Full Text] [Related]
19. PRDX2 in Myocyte Hypertrophy and Survival is Mediated by TLR4 in Acute Infarcted Myocardium.
Jin X; Chen C; Li D; Su Q; Hang Y; Zhang P; Hu W
Sci Rep; 2017 Aug; 7(1):6970. PubMed ID: 28765537
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.
Zhang S; Fu Z; Wei J; Guo J; Liu M; Du K
Med Oncol; 2015 Jan; 32(1):414. PubMed ID: 25471788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
